Cloning and expression in Escherichia coli of an azoreductase gene from Clostridium perfringens and comparison with azoreductase genes from other bacteria

Journal of Basic Microbiology

Volumn 39, Issue 1, 1999, Pages 29-35

  Rafii, Fatemeh ^a   Coleman, Teresa ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZO REDUCTASE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLONING VECTOR; DNA DNA HYBRIDIZATION; DNA FRAGMENT; ENZYME ACTIVITY; GENE EXPRESSION; GENE SEQUENCING; GENETIC CONSERVATION; GENOME LIBRARY; MOLECULAR CLONING; PHAGE DISPLAY; POLYMERASE CHAIN REACTION;

BACTERIA; BACTERIOPHAGES; CLONING, MOLECULAR; CLOSTRIDIUM PERFRINGENS; COLORING AGENTS; ESCHERICHIA COLI; GENES, BACTERIAL; HUMANS; NADH, NADPH OXIDOREDUCTASES; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); CITROBACTER AMALONATICUS; CLOSTRIDIUM PERFRINGENS; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EUBACTERIUM SP.; PROKARYOTA;

EID: 0033066384     PISSN: 0233111X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4028(199903)39:1<29::AID-JOBM29>3.0.CO;2-W     Document Type: Article

References (20)

1. BRAGGER, J. L., LLOYD A. W., SOOZANDEHFAR, S. H., BLOOMFIELD, S.C., MARRIOTT, C. and MARTIN, G. P., 1997. Investigations into the azo reducing activity of a common colonic microorganism. Int. J. Pharmaceut., 157, 61-71.
2. BROWN, J. P., MCGARRAUGH, G. V., PARKINSON, T. M. and WINGARD, Jr., R. E., 1983. A polymeric drug for treatment of inflammatory bowel disease. J. Med. Chem., 26, 1300-1307.
3. CERNIGLIA, C. E., ZHOU, Z., MANNING, B. W., FEDERLE, T. W. and HEFLICH, R. H., 1986. Mutagenic activation of the benzidine-based dye Direct Black 38 by human intestinal microflora. Mutat. Res., 175, 11-16.
4. COLLIER, S. W., STORM, J. E. and BRONAUGH, R. L., 1993. Reduction of azo dyes during in vitro percutaneous absorption. Toxicol. Appl. Pharmacol., 118, 73-79.
5. DILLON, D., COMBES, R. and ZEIGER, E., 1994. Activation by caecal reduction of the azo dye D&C Red No. 9 to a bacterial mutagen. Mutagenesis, 9, 295-299.
6. GARNER, R. C. and NUTMAN, C. A., 1977. Testing of some azo dyes and their reduction products for mutagenicity using Salmonella typhimurium TA1538. Mutat. Res., 44, 9-19.
7. GHOSH, D. K., GHOSH, S., SADHUKHAN, P., MANDAL, A. and CHAUDHURI, J., 1993. Purification of two azoreductases from Escherichia coli K12. Ind. J. Exp. Biol., 31, 951-954.
8. HUYNH, T. V., YOUNG, R. A. and DAVIS, R. W., 1985. Constructing and screening cDNA libraries in λgt10 and λgt11. In: DNA Cloning (GLOVER, D. M., Editor), pp. 49-78. Vol. 1. IRL Press, Ltd., Oxford.
9. LEVINE, W. G., 1991. Metabolism of azo dyes: Implications for detoxification and activation. Drug Metab. Rev., 23, 253-309.
10. MARMION, D. M., 1991. Handbook of U.S. Colorants: Foods, Drugs and Cosmetics, and Medical Devices. (Third Edn.). John Wiley & Sons, New York.
11. RAFII, F., FRANKLIN, W. and CERNIGLIA, C. E., 1990. Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora. Appl. Environ. Microbiol., 56, 2146-2151.
12. RAFII, F., SMITH, D. B., BENSON, R. W. and CERNIGLIA, C. E., 1992. Immunological homology among azoreductases from Clostridium and Eubacterium strains isolated from human intestinal microflora. J. Basic Microbiol., 32, 99-105.
13. RAFII, F. and CERNIGLIA, C. E., 1993. Comparison of the azoreductase and nitroreductase from Clostridium perfringens. Appl. Environ. Microbiol., 59, 1731-1734.
14. RAFII, F., MOORE, J. D., RUSELER-VAN EMBDEN, J. G. H. and CERNIGLIA, C. E., 1995. Bacterial reduction of azo dyes used in foods and drugs and cosmetics. Microecol. Therap., 25, 147-156
15. RAIN, C. P., NOBLE, S. and FAULDS, D., 1995. Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drugs., 50, 137-156.
16. SAMBROOK, J., FRITSCH, F. F. and MANIATIS, T., 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. (2nd Ed.). Vol. 3, pp. E3-E10.
17. SHANTHA, K. L., RAVICHANDRAN, P. and RAO, K. P., 1995. Azo polymeric hydrogels for colon targeted drug delivery. Biomaterials, 16, 1313-1318.
18. VAN DEN MOOTER, G., MARIS, B., SAMYN, C., AUGUSTIJNS, P. and KINGET R., 1995. Use of azopolymers for colon-specific drug delivery. J. Pharm. Sci., 86, 1321-1327.
19. WATABE, T., OZAWA, N. and KOBAYASHI, F., 1980. Reduction of sulphonated water-soluble azo dyes by micro-organisms from human faeces. Food. Cosmet. Toxicol., 18, 349-352.
20. ZBAIDA, S., BREWER, C. F. and LEVINE, W. G., 1994. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials. Drug Metab. Dispos., 22, 412-418.